2010
DOI: 10.1111/j.1474-9726.2010.00546.x
|View full text |Cite
|
Sign up to set email alerts
|

Neuronal expression of a single‐subunit yeast NADH–ubiquinone oxidoreductase (Ndi1) extends Drosophila lifespan

Abstract: SummaryThe 'rate of living' theory predicts that longevity should be inversely correlated with the rate of mitochondrial respiration. However, recent studies in a number of model organisms, including mice, have reported that interventions that retard the aging process are, in fact, associated with an increase in mitochondrial activity. To better understand the relationship between energy metabolism and longevity, we supplemented the endogenous respiratory chain machinery of the fruit fly Drosophila melanogaste… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
80
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 56 publications
(84 citation statements)
references
References 53 publications
1
80
0
Order By: Relevance
“…Indeed, part of the effect of dFOXO on lifespan could be mediated by its repression of the components of complex I, because reducing the electron flow through this complex, by bypassing it, can extend fly lifespan [41], [42].…”
Section: Resultsmentioning
confidence: 99%
“…Indeed, part of the effect of dFOXO on lifespan could be mediated by its repression of the components of complex I, because reducing the electron flow through this complex, by bypassing it, can extend fly lifespan [41], [42].…”
Section: Resultsmentioning
confidence: 99%
“…One of these, NADH dehydrogenase internal 1 ( ndi1 ) is functional in higher metazoans, including mammals, acting as a non-proton translocating NADH dehydrogenase/ubiquinone oxidoreductase in the mitochondrial matrix (Yagi et al 2006). Transgenic expression of ndi1 in D. melanogaster rescues loss of endogenous complex I (Cho et al 2012) and expression in flies without complex I defects supplements and boosts endogenous NADH dehydrogenase/ubiquinone oxidoreductase activity in a rotenone-insensitive manner (Sanz et al 2010; Bahadorani et al 2010; Hur et al 2013). Critically, unlike dPGC-1 , this increase in complex I-like activity was achieved without significant changes to other ETC complexes (Sanz et al 2010; Bahadorani et al 2010).…”
Section: Increasing Complex I and Lifespanmentioning
confidence: 99%
“…Transgenic expression of ndi1 in D. melanogaster rescues loss of endogenous complex I (Cho et al 2012) and expression in flies without complex I defects supplements and boosts endogenous NADH dehydrogenase/ubiquinone oxidoreductase activity in a rotenone-insensitive manner (Sanz et al 2010; Bahadorani et al 2010; Hur et al 2013). Critically, unlike dPGC-1 , this increase in complex I-like activity was achieved without significant changes to other ETC complexes (Sanz et al 2010; Bahadorani et al 2010). Like dPGC-1 , expression of ndi1 in flies resulted in increased markers of complex I-like activity, extended longevity, and reduced ROS levels (Sanz et al 2010; Bahadorani et al 2010; Hur et al 2013).…”
Section: Increasing Complex I and Lifespanmentioning
confidence: 99%
“…Additionally, yeast Ndi1 has been shown to have therapeutic benefit in several Parkinson's disease models [14][15][16][17][18][19] and evidence supporting a possible use in anti-cancer treatment has also been put forward [20]. Many other physiological effects were also reported in model organisms expressing yeast Ndi1, including extended lifespan [9,21] and resistance to particular stresses [9]. Intriguingly, the alternative NADH dehydrogenases show some sequence similarity with AIF (apoptosis-inducing factor) and the S. cerevisiae Ndi1 protein has been shown to be capable of inducing apoptosis [22,23].…”
Section: Introductionmentioning
confidence: 95%
“…Whilst the therapeutic potential of alternative NADH dehydrogenase has been demonstrated on diverse models, using S. cerevisiae Ndi1 [8][9][10][11][12][13][14][15][16][17][18][19][20][21], the yeast enzyme may not be optimal for such use, for several reasons. First, and most importantly, it exists in vivo without the presence of cI.…”
Section: Introductionmentioning
confidence: 99%